Categories
Stomach cancer laboratory findings
From Wikidoc - Reading time: 3 min
|
Stomach cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Stomach cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Stomach cancer laboratory findings |
|
Risk calculators and risk factors for Stomach cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview[edit | edit source]
Laboratory findings in gastric cancer include anemia of chronic disease on complete blood count, liver function tests may reveal abnormalities in liver function tests, antigens such as carcinoembryonic antigen, glycoprotein CA 125, carbohydrate antigen 19-9, cancer antigen 72-4, alpha-fetoprotein.
Stomach cancer laboratory findings[edit | edit source]
- A complete blood cell count shows anemia of chronic disease.
- Liver function tests may be disturbed in patients with liver metastasis.
- Carcinoembryonic antigen (CEA) is elevated in 50% of patients. A drop in an elevated level of CEA means response to preoperative therapy but it is not sensitive or specific.
- Glycoprotein CA 125 antigen may be elevated.[1]
- Carbohydrate antigen 19-9 (CA 19-9) is elevated.[2]
- Cancer antigen 72-4 (CA72-4) may be elevated.[3]
- Alpha-fetoprotein (AFP) may be elevated.[4]
References[edit | edit source]
- ↑ Luo T, Chen W, Wang L, Zhao H (2016). "CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study". Medicine (Baltimore). 95 (51): e5297. doi:10.1097/MD.0000000000005297. PMC 5181804. PMID 28002320.
- ↑ Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M (2008). "Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer". Adv Ther. 25 (10): 1075–84. doi:10.1007/s12325-008-0100-4. PMID 18821070.
- ↑ Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Cavaliere F; et al. (1995). "CA 72-4 serum marker--a new tool in the management of carcinoma patients". Cancer Invest. 13 (2): 227–38. PMID 7874576.
- ↑ Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H; et al. (2002). "Clinicopathologic features of gastric cancers producing alpha-fetoprotein". Dig Surg. 19 (5): 359–65, discussion 365. doi:10.1159/000065838. PMID 12435906.
Licensed under CC BY-SA 3.0 | Source: https://www.wikidoc.org/index.php/Stomach_cancer_laboratory_findings10 views | Status: cached on October 11 2025 08:45:32↧ Download this article as ZWI file
EncycloReader
is supported by the 
KSF